Yu D, Gao X, Shao F, Liu Z, Liu A, Zhao M
Cell Mol Immunol. 2025; .
PMID: 39962263
DOI: 10.1038/s41423-025-01267-w.
Wang X, Yu G
Front Vet Sci. 2025; 11:1524668.
PMID: 39881716
PMC: 11776093.
DOI: 10.3389/fvets.2024.1524668.
Pongma C, Keawvilai P, Boonmee A, Wongprom B, Pattarakankul T, Sittplangkoon C
Sci Rep. 2025; 15(1):1146.
PMID: 39774150
PMC: 11706949.
DOI: 10.1038/s41598-025-85234-5.
Peters J, Irvine E, Makatsa M, Rosenberg J, Wadsworth 2nd M, Hughes T
Sci Adv. 2025; 11(1):eadq8229.
PMID: 39742484
PMC: 11694782.
DOI: 10.1126/sciadv.adq8229.
Millet N, Sekar J, Solis N, Millet A, Aggor F, Wildeman A
bioRxiv. 2024; .
PMID: 39314368
PMC: 11419061.
DOI: 10.1101/2024.09.08.611873.
Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials.
Jain H, Odat R, Hussein A, Dey D, Ahmed M, Jain J
Ann Med Surg (Lond). 2024; 86(9):5439-5446.
PMID: 39239021
PMC: 11374198.
DOI: 10.1097/MS9.0000000000002370.
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.
Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y
ACS Nano. 2024; 18(36):24650-24681.
PMID: 39185745
PMC: 11394369.
DOI: 10.1021/acsnano.3c10797.
Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in Preventing COVID-19 Infection.
Noval Rivas M, Rosser C, Arditi M
Bladder Cancer. 2024; 7(2):121-131.
PMID: 38994533
PMC: 11181712.
DOI: 10.3233/BLC-201529.
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
Malireddi R, Sharma B, Kanneganti T
Annu Rev Immunol. 2024; 42(1):615-645.
PMID: 38941608
PMC: 11373870.
DOI: 10.1146/annurev-immunol-083122-043545.
Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2.
Sanchez-Morales L, Porras N, Garcia-Seco T, Perez-Sancho M, Cruz F, Chinchilla B
Vet Res. 2024; 55(1):71.
PMID: 38822398
PMC: 11143641.
DOI: 10.1186/s13567-024-01325-7.
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
Kumar A, Tripathi P, Kumar P, Shekhar R, Pathak R
Vaccines (Basel). 2024; 12(5).
PMID: 38793710
PMC: 11125746.
DOI: 10.3390/vaccines12050459.
Multiparameter Flow Cytometry Monitoring of T Cell Responses.
Maecker H
Methods Mol Biol. 2024; 2807:325-342.
PMID: 38743238
DOI: 10.1007/978-1-0716-3862-0_22.
BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
Iqbal N, Ahmed K, Sattar T, Aziz F, Hussain R
PLoS One. 2024; 19(5):e0302722.
PMID: 38722827
PMC: 11081370.
DOI: 10.1371/journal.pone.0302722.
Non-specific protection against severe COVID-19 associated to typhoid fever and DTP vaccination.
Juste R, Vrotsou K, Mateo-Abad M, Gutierrez-Stampa M, Rotaeche R, Vergara I
Heliyon. 2024; 10(9):e29935.
PMID: 38707311
PMC: 11068531.
DOI: 10.1016/j.heliyon.2024.e29935.
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023.
Burak M, Stanley T, Lawson E, Campbell S, Lynch L, Hasty A
Am J Clin Nutr. 2024; 120(1):257-268.
PMID: 38705359
PMC: 11347817.
DOI: 10.1016/j.ajcnut.2024.04.029.
STING-dependent trained immunity contributes to host defense against Clostridium perfringens infection via mTOR signaling.
Liu Z, Zhou C, Lin X, Gao Y, Luo X, Zhang J
Vet Res. 2024; 55(1):52.
PMID: 38622656
PMC: 11017476.
DOI: 10.1186/s13567-024-01301-1.
Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bCD27 memory-like NK cells.
Khalifa A, Nakamura T, Sato Y, Harashima H
Exp Hematol Oncol. 2024; 13(1):36.
PMID: 38553761
PMC: 10981311.
DOI: 10.1186/s40164-024-00502-w.
The Influence of Cross-Reactive T Cells in COVID-19.
Eggenhuizen P, Ooi J
Biomedicines. 2024; 12(3).
PMID: 38540178
PMC: 10967880.
DOI: 10.3390/biomedicines12030564.
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.
Manfrini N, Notarbartolo S, Grifantini R, Pesce E
Antibodies (Basel). 2024; 13(1).
PMID: 38390874
PMC: 10885122.
DOI: 10.3390/antib13010013.
Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions.
Wang G, Wang Y, Ma F
Cell Biosci. 2024; 14(1):24.
PMID: 38368397
PMC: 10874560.
DOI: 10.1186/s13578-024-01207-7.
